Search research articles
Contact Us
Filters
Showing results (21-30 of 63) with videos related to
Page
of 7
Sort By:
Joint Bone Spine
|
December 2, 2023
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies
Kim Lauper, Denis Mongin, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases
|
September 13, 2022
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries
Manuel Pombo-Suarez, Carlos Sanchez-Piedra, Juan Gómez-Reino, et al.
RMD Open
|
November 3, 2024
Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis: results from nine European rheumatology registries
Lykke M Ørnbjerg, Stylianos Georgiadis, Tore K Kvien, et al.
Arthritis Research & Therapy
|
September 30, 2025
Sacroiliac joint involvement in psoriatic arthritis - MRI, radiographic and clinical findings in 581 European routine care patients
Nora Vladimirova, Anna Ef Hadsbjerg, Simon Krabbe, et al.
Rheumatology (Oxford, England)
|
August 19, 2020
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries
Delphine S Courvoisier, Katarina Chatzidionysiou, Denis Mongin, et al.
BMC Rheumatology
|
July 11, 2025
The relationship between lifestyle factors and outcome of treatment with TNFα inhibitors in axial spondyloarthritis - results from 14 European countries
Gareth T Jones, Ovidiu Rotariu, Ross MacDonald, et al.
RMD Open
|
December 17, 2025
Discrepancies between routine sacroiliac joint MRI reporting and current expert recommendations in patients with spondyloarthritis
Anna E F Hadsbjerg, Simon Krabbe, Nora Vladimirova, et al.
Rheumatology (Oxford, England)
|
September 22, 2023
Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching
Louise Linde, Lykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 15, 2025
Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries
Romain Aymon, Denis Mongin, Romain Guemara, et al.
Annals of the Rheumatic Diseases
|
December 10, 2023
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study)
Romain Aymon, Denis Mongin, Sytske Anne Bergstra, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 63) with videos related to
Sort By:
Page
of 7
Joint Bone Spine
|
December 2, 2023
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies
Kim Lauper, Denis Mongin, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases
|
September 13, 2022
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries
Manuel Pombo-Suarez, Carlos Sanchez-Piedra, Juan Gómez-Reino, et al.
RMD Open
|
November 3, 2024
Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis: results from nine European rheumatology registries
Lykke M Ørnbjerg, Stylianos Georgiadis, Tore K Kvien, et al.
Arthritis Research & Therapy
|
September 30, 2025
Sacroiliac joint involvement in psoriatic arthritis - MRI, radiographic and clinical findings in 581 European routine care patients
Nora Vladimirova, Anna Ef Hadsbjerg, Simon Krabbe, et al.
Rheumatology (Oxford, England)
|
August 19, 2020
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries
Delphine S Courvoisier, Katarina Chatzidionysiou, Denis Mongin, et al.
BMC Rheumatology
|
July 11, 2025
The relationship between lifestyle factors and outcome of treatment with TNFα inhibitors in axial spondyloarthritis - results from 14 European countries
Gareth T Jones, Ovidiu Rotariu, Ross MacDonald, et al.
RMD Open
|
December 17, 2025
Discrepancies between routine sacroiliac joint MRI reporting and current expert recommendations in patients with spondyloarthritis
Anna E F Hadsbjerg, Simon Krabbe, Nora Vladimirova, et al.
Rheumatology (Oxford, England)
|
September 22, 2023
Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching
Louise Linde, Lykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 15, 2025
Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries
Romain Aymon, Denis Mongin, Romain Guemara, et al.
Annals of the Rheumatic Diseases
|
December 10, 2023
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study)
Romain Aymon, Denis Mongin, Sytske Anne Bergstra, et al.
Page
of 7